SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BREVEGLIERI, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.458
AS - Asia 6.428
EU - Europa 4.600
SA - Sud America 1.048
Continente sconosciuto - Info sul continente non disponibili 324
AF - Africa 173
OC - Oceania 26
AN - Antartide 1
Totale 25.058
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.949
SG - Singapore 2.236
CN - Cina 1.872
IT - Italia 1.294
PL - Polonia 869
BR - Brasile 828
VN - Vietnam 677
DE - Germania 529
HK - Hong Kong 489
UA - Ucraina 442
GB - Regno Unito 350
TR - Turchia 268
FR - Francia 240
FI - Finlandia 215
SE - Svezia 206
CA - Canada 196
JP - Giappone 161
RU - Federazione Russa 155
BD - Bangladesh 146
IN - India 140
ID - Indonesia 104
MX - Messico 85
NL - Olanda 76
AR - Argentina 75
ZA - Sudafrica 52
ES - Italia 37
IQ - Iraq 37
BE - Belgio 36
EC - Ecuador 36
IR - Iran 35
PK - Pakistan 35
CO - Colombia 34
GT - Guatemala 31
HN - Honduras 30
VE - Venezuela 30
CR - Costa Rica 27
PR - Porto Rico 27
UZ - Uzbekistan 25
KR - Corea 23
MA - Marocco 23
MY - Malesia 22
NI - Nicaragua 21
AU - Australia 20
LT - Lituania 20
PH - Filippine 20
CW - ???statistics.table.value.countryCode.CW??? 19
CZ - Repubblica Ceca 19
JM - Giamaica 19
SV - El Salvador 19
IL - Israele 17
TN - Tunisia 17
TT - Trinidad e Tobago 17
SA - Arabia Saudita 16
KE - Kenya 15
AE - Emirati Arabi Uniti 14
CH - Svizzera 14
EG - Egitto 14
CL - Cile 13
GP - Guadalupe 12
PT - Portogallo 12
SC - Seychelles 12
IE - Irlanda 11
PE - Perù 11
PY - Paraguay 11
AT - Austria 9
AZ - Azerbaigian 9
DZ - Algeria 9
EE - Estonia 9
ET - Etiopia 9
RO - Romania 9
TW - Taiwan 9
NP - Nepal 8
JO - Giordania 7
KZ - Kazakistan 7
LB - Libano 7
LV - Lettonia 7
BG - Bulgaria 6
GR - Grecia 6
PA - Panama 6
TH - Thailandia 6
BB - Barbados 5
BH - Bahrain 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
SI - Slovenia 5
UY - Uruguay 5
GE - Georgia 4
KW - Kuwait 4
PS - Palestinian Territory 4
RS - Serbia 4
YE - Yemen 4
BO - Bolivia 3
BS - Bahamas 3
DK - Danimarca 3
HU - Ungheria 3
NG - Nigeria 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
BY - Bielorussia 2
Totale 24.706
Salva come PNG Salva come JPEG
Città #
Ashburn 1.470
Singapore 1.408
San Jose 943
Warsaw 855
Beijing 707
Woodbridge 699
Council Bluffs 578
Fairfield 560
Chandler 557
Houston 501
Ann Arbor 492
Jacksonville 489
Santa Clara 484
Hong Kong 475
Ferrara 299
Wilmington 276
Seattle 246
Dallas 241
Ho Chi Minh City 228
New York 223
Nanjing 184
Los Angeles 182
Cambridge 168
Hanoi 167
Tokyo 149
Izmir 146
Bologna 133
Milan 132
Princeton 118
Munich 109
Lauterbourg 102
Boardman 91
Addison 84
Shanghai 79
Jakarta 68
Helsinki 66
Orem 66
Rome 58
Shenyang 58
São Paulo 58
San Diego 56
Bremen 55
Brooklyn 51
Mexico City 50
Montreal 49
Toronto 49
Phoenix 48
Redwood City 48
Chicago 47
Nanchang 46
London 45
Turku 42
Chennai 40
Denver 40
Buffalo 38
Da Nang 36
Falls Church 36
Rio de Janeiro 36
Hebei 35
Frankfurt am Main 34
Dearborn 33
Haiphong 33
Hefei 33
North Bergen 33
Moscow 32
Stockholm 32
Guangzhou 31
San Francisco 31
Brussels 30
Hangzhou 30
Johannesburg 29
Zhengzhou 29
Changsha 28
Manchester 28
Atlanta 27
Tianjin 27
Verona 25
Auburn Hills 24
Jiaxing 24
Naples 24
Brasília 23
Guatemala City 23
Poplar 22
San José 22
Tashkent 22
The Dalles 22
Managua 21
Mountain View 21
Curitiba 20
Guayaquil 20
Charlotte 19
Dong Ket 19
Philadelphia 18
Willemstad 18
Amsterdam 17
Nuremberg 17
Boston 16
Columbus 16
Norwalk 16
San Salvador 16
Totale 15.801
Salva come PNG Salva come JPEG
Nome #
A validated cellular biobank for β-thalassemia 449
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 447
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 405
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays 392
A validated THALAMOSS cellular biobank for β-thalassemia 372
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 336
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 331
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 318
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 309
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 294
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 287
SPR-based non-invasive prenatal testing for fetal sex determination 279
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells 277
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 273
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 267
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 260
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 255
Droplet Digital PCR for Non-Invasive Prenatal Detection of Fetal Single-Gene Point Mutations in Maternal Plasma 253
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 248
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 245
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 241
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 240
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 240
Surface plasmon resonance analysis to detect the β+ IVSI-110 thalassemia mutation in circulating cell-free fetal DNA 238
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 236
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 235
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 235
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 230
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 228
Constitutive systemic inflammation in Shwachman-Diamond Syndrome 225
Antisense PNA and PNA-peptide conjugates for the modulation of the beta-globin gene splicing 223
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 220
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 218
Non-invasive fetal sex diagnosis in plasma of early weeks pregnants using droplet digital PCR 217
Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor 217
Cellular biosensors for the identification of fetal hemoglobin inducers 216
Alteration of microRNA biological activity with peptide nucleic acid 215
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 215
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 213
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 212
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 208
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 205
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 205
Effect of bioencapsulation on the secretomic profile o fIB3-1 cystic fibrosis cells 204
Development and molecular characterization of transgenic mice for beta-thalassemia 204
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 204
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 200
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 200
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 197
Detection methods for the identification of Alicyclobacillus species involved in food spoilage 195
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 194
Real-time multiplex analysis of four beta-thalassemia mutations employing surface plasmon resonance and biosensor technology 189
Gene therapy and fetal hemoglobin induction 184
IL-17 family members exert an autocrine pro-inflammatory loop in CF respiratory epithelial cells ex vivo 181
Gene therapy combined with HbF induction in beta-thalassemia 181
Modulation of the Biological Activity of microRNA-210 with Peptide Nucleic Acids (PNAs) 178
Evidences for miRNA regulation of BCL11A gene expression 175
Non-invasive Prenatal Testing Using Fetal DNA 174
Targeting the miR-221/miR-222 cluster in cancer therapy 173
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients 171
A Signature of Differentially Expressed Micrornas in Lymphoblastoid Cells from Shwachman-Diamond Syndrome Patients Indicates Possible Molecular Targets for Mirna Therapeutics 171
Non-invasive prenatal detection of beta-thalassemia mutations in maternal plasma using Droplet Digital PCR 170
Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. 168
TNF-alpha induced release of IL-8 by IB3-1 cells encapsulated in alginate microbeads 165
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 164
Peptide nucleic acids targeting miR-221 in human breast cancer: uptake and modulation of miR-221 biological functions. 163
In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR 163
Detection of disorders in unamplified human genomic DNA 162
Surface plasmon resonance and biosensor technology for real-time molecular diagnosis of β°39 thalassemia mutation 160
Sirolimus-mediated induction of fetal hemoglobin in beta-thalassemia: impact of the XmnI rs74482144 polymophism 156
Transcription factors (TFs) negatively regulating gamma-globin gene transcription: BCL11A is down-regulated during mithramycin induction of erythroid cells from beta-thalassemia patients 154
Set up of a NK cell-sensitive tumour model in C57BL/6 mice 151
Detection of genomic disorders in unamplified human genomic DNA using an ultrasensitive surface plasmon resonance imaging method 151
Up-regulation of miR-34a-3p and miR-744-3p is associated with down-regulation of PTEN in lymphoblastoid cells from Shwachman-Diamond Syndrome patients 151
Peptide nucleic acids targeting miR-221 in breast cancer cell lines: uptake and modulation of miR-221 and p27kip1 biological function 150
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 150
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 149
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 147
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 147
Inhibition of micro RNA 210 biological activity with an anti-miR-210 peptide nucleic acid 147
Produzione di emoglobina in cellule Eritroidi da pazienti con Beta Talassemia alterando processi biomolecolari in grado di regolare l'espressione dei geni per le globine. 147
PNA-mediated alteration of mRNA splicing 146
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 146
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 146
Surface Plasmon Resonance Imaging (SPR-I), peptide nucleic acid (PNA) probes and nanoparticle-enhancement for PCR-free ultrasensitive detection of beta-thalassemia mutations in human genomic DNA 146
P1 promoter transcriptional activity of the human AbetaH-J-J locus, encoding Aspartil-beta-hydroxylase, Junctin and Junctate 145
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 144
MTOR and STAT3 pathway hyper-activation is associated with elevated interleukin-6 levels in patients with shwachman-diamond syndrome: Further evidence of lymphoid lineage impairment 144
Multiple levels of control of the expression of the human AβH-J-J locus encoding aspartyl-β-hydroxylase, junctin, and junctate 139
UPF1 silenced cellular model systems for screening of read-through agents active on β039 thalassemia point mutation 138
Production of a cellular model for the screening of inducers of fetal haemoglobin 136
Generation and molecular characterization of a transgenic mouse line carrying a mutated human β°39 thalassemia β-globin gene 136
SPR-based identification of microRNAs 135
Induction of high levels of apoptosis of temozolomide-resistant T98G glioma cells by co-administration of peptide nucleic acids targeting miR-221 and miR-222 134
Human bladder carcinoma cell line 5637 encapsulated in alginate microbeads: release of interleukins, chemokines and growth factors. 133
Secretome Release During In Vitro Bone Marrow-Derived Mesenchymal Stem Cell Differentiation Induced by Bio-Oss® Collagen Material 131
Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus 129
Exploring MyomiRs Dysregulation in Limb Girdle Muscular Dystrophy D2 128
Molecular regulation of the expression of AbetaHJ-J locus, encoding Aspartyl-beta-hydroxylase, Junctin and Junctate 127
Black Garlic: Evolution of the Chemical Composition and Broad Biological Activities 127
Totale 20.529
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.954
Totale 108.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022908 0 0 0 0 85 70 60 48 51 110 104 380
2022/20231.278 137 124 25 161 224 167 74 116 130 10 52 58
2023/2024808 50 107 35 31 64 156 82 42 11 16 52 162
2024/20252.965 80 70 230 154 305 246 127 144 511 327 391 380
2025/20268.495 818 318 670 1.012 1.252 562 1.020 534 789 970 370 180
2026/20273.102 312 541 996 1.099 154 0 0 0 0 0 0 0
Totale 25.058